We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
Impact of maternal serum uric acid on perinatal outcome in women with hypertensive disorders of pregnancy: A prospective study.
Pregnancy Hypertension 2017 October
INTRODUCTION: Worldwide hypertensive disorder of pregnancy is major cause of maternal and perinatal morbidity, mortality.
AIM: To study impact of maternal serum uric acid on perinatal outcome in women with hypertensive disorder of pregnancy.
METHODOLOGY: Present study was conducted in Obstetrics and Gynecology Department of rural tertiary care centre of Northern India over seven months (October 2016-May 2017). Total 110 pregnant women >-34weeks with hypertensive disorder of pregnancy were divided into three groups; Gestational hypertension (n = 35), Pre-eclampsia (n = 49), Eclampsia (n = 26). Maternal serum uric acid and its co-relation with perinatal outcome were assessed in each group.
RESULTS: Of total 111 babies delivered to women with hypertensive disorder of pregnancy, 52 (46.85%) were preterm and 59 (53.15%) term. Of these; 43 (38.74%) were born healthy (APGAR > 7), 31 (27.93%) suffered minimal respiratory distress, 14 (12.61%) severe birth asphyxia and required ventilator support, of which two died, 19 (17.12%) babies died in utero and 4 (3.60%) were still births. Mean neonatal birth weight in all three groups was 2.956 ± 0.273 kg, 2.475 ± 0.324 kg and 2.177 ± 0.282 kg respectively. Mean serum uric acid in gestational hypertension women with healthy foetuses was 5.16 ± 1.74 mg/dl and with distressed foetuses was 6.52 ± 2.31 mg/dl, in pre-eclampsia it was 5.3 ± 1.44 mg/dl and 7.29 ± 2.63 mg/dl and in eclamptic women 5.7 ± 0 mg/dl and 8.83 ± 2.96 mg/dl respectively.
CONCLUSION: Adverse perinatal outcome was maximum in eclampsia group, followed by pre-eclampsia and lastly in gestational hypertension. Hence, higher maternal serum uric acid was associated with poor perinatal outcome (p < .05).
AIM: To study impact of maternal serum uric acid on perinatal outcome in women with hypertensive disorder of pregnancy.
METHODOLOGY: Present study was conducted in Obstetrics and Gynecology Department of rural tertiary care centre of Northern India over seven months (October 2016-May 2017). Total 110 pregnant women >-34weeks with hypertensive disorder of pregnancy were divided into three groups; Gestational hypertension (n = 35), Pre-eclampsia (n = 49), Eclampsia (n = 26). Maternal serum uric acid and its co-relation with perinatal outcome were assessed in each group.
RESULTS: Of total 111 babies delivered to women with hypertensive disorder of pregnancy, 52 (46.85%) were preterm and 59 (53.15%) term. Of these; 43 (38.74%) were born healthy (APGAR > 7), 31 (27.93%) suffered minimal respiratory distress, 14 (12.61%) severe birth asphyxia and required ventilator support, of which two died, 19 (17.12%) babies died in utero and 4 (3.60%) were still births. Mean neonatal birth weight in all three groups was 2.956 ± 0.273 kg, 2.475 ± 0.324 kg and 2.177 ± 0.282 kg respectively. Mean serum uric acid in gestational hypertension women with healthy foetuses was 5.16 ± 1.74 mg/dl and with distressed foetuses was 6.52 ± 2.31 mg/dl, in pre-eclampsia it was 5.3 ± 1.44 mg/dl and 7.29 ± 2.63 mg/dl and in eclamptic women 5.7 ± 0 mg/dl and 8.83 ± 2.96 mg/dl respectively.
CONCLUSION: Adverse perinatal outcome was maximum in eclampsia group, followed by pre-eclampsia and lastly in gestational hypertension. Hence, higher maternal serum uric acid was associated with poor perinatal outcome (p < .05).
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app